Gut permeability and mucosal inflammation: bad, good or context dependent

Area of Science:

• Gastroenterology
• Immunology
• Cell Biology

Background:

• Inflammatory bowel disease (IBD) pathogenesis is multifactorial.
• A compromised mucosal barrier, or "leaky gut," is implicated in promoting inflammation via heightened immune activation.
• Maintaining mucosal homeostasis requires interaction between luminal antigens and the mucosal immune system.

Purpose of the Study:

• To review mouse model outcomes of altered gut permeability due to manipulating mucosal barrier-associated proteins.
• To highlight the significance of gut permeability in regulating mucosal inflammation.
• To emphasize the non-barrier-related roles of mucosal proteins in chronic inflammatory conditions.

Main Methods:

• Review of recent mouse models with altered gut permeability.
• Analysis of direct and indirect effects of manipulating mucosal barrier-associated proteins.
• Examination of epithelial repair, differentiation, proliferation, and apoptosis.

Main Results:

• Deregulation of gut permeability can increase susceptibility to colitis and adaptive immunity in mice.
• Compromised gut permeability alone may not be sufficient to induce colitis.
• Manipulations of barrier-associated proteins affect epithelial cell dynamics and gut barrier function.

Conclusions:

• The relationship between gut permeability and immune homeostasis is complex and dynamic.
• Mucosal barrier-associated proteins play multifaceted roles beyond barrier integrity in inflammatory diseases.
• Understanding these complex interactions is crucial for managing chronic mucosal inflammatory conditions like IBD.